FDA Inspection 802592 — Novo Nordisk Pharmaceutical Industries LP
The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries LP on Aug 16, 2012 in Clayton, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Clayton, NC (United States)